|
Barry E. Greene founded Vicarious Surgical, Inc. Presently, Dr. Greene is President, Chief Executive Officer & Director at SAGE Therapeutics, Inc.
He is also on the board of Acorda Therapeutics, Inc., Karyopharm Therapeutics, Inc. and BCLS Acquisition Corp. and Chief Medical Officer at Vicarious Surgical, Inc.
In the past he was President of Alnylam Pharmaceuticals, Inc., Partner at Andersen Consulting LLP (GB), Vice President-Marketing & Customer Services at AstraZeneca Plc and Vice President-Strategic Integration at AstraZeneca Pharmaceuticals LP (a subsidiary of AstraZeneca Plc), Partner at Accenture Ltd., Chief Business Officer & Executive Vice President at Mediconsult.com, Inc. and General Manager-Oncology Division at Millennium Pharmaceuticals, Inc.
Dr. Greene received an undergraduate degree from the University of Pittsburgh.
|
Current positions of Barry Greene | |
|
|
|
Name | Equities | % | Valuation |
Alnylam Pharmaceuticals, Inc. (ALNY) (Biotechnology & Medical Research) | 73,501 | 0.063% | 9,552,925 USD |
BCLS Acquisition Corp. | 30,000 | 0.84% | 334,200 USD |
Karyopharm Therapeutics Inc. (KPTI) (Biotechnology & Medical Research) | 6,030 | 0.0082% | 93,344 USD |
Acorda Therapeutics, Inc. (ACOR) () | 1,273 | 0.0027% | 878 USD |
Sage Therapeutics, Inc. (SAGE) (Biotechnology & Medical Research) | 0 | 0.0000% | 0 USD |
|
Barry Greene : Personal Network | |
|
Name | Linked companies |
Jeffrey Jonas | Sage Therapeutics, Inc. |
Steven Marc Paul | Sage Therapeutics, Inc. |
Kimi E. Iguchi | Sage Therapeutics, Inc. |
Anne Marie Cook | Sage Therapeutics, Inc. |
James M. Frates | Sage Therapeutics, Inc. |
Kevin Starr | Sage Therapeutics, Inc. |
Michael F. Cola | Sage Therapeutics, Inc. |
Geno J. Germano | Sage Therapeutics, Inc. |
Erin E. Lanciani | Sage Therapeutics, Inc. |
George S. Golumbeski | Sage Therapeutics, Inc. |
|
© 2021 People and Ownership :
|
|
|
Barry Greene : Connections | |
|
|
Latest news about Barry Greene | |
|
|
|